Naoko Takei

449 total citations
14 papers, 340 citations indexed

About

Naoko Takei is a scholar working on Pharmacology, Hematology and Molecular Biology. According to data from OpenAlex, Naoko Takei has authored 14 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Naoko Takei's work include Acute Myeloid Leukemia Research (3 papers), Pharmacy and Medical Practices (3 papers) and Protein Degradation and Inhibitors (3 papers). Naoko Takei is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Pharmacy and Medical Practices (3 papers) and Protein Degradation and Inhibitors (3 papers). Naoko Takei collaborates with scholars based in Japan. Naoko Takei's co-authors include Tomokazu Yoshimura, Kunio Esumi, Toshiro Nagasawa, Seiichi Shimizu, Hiroshi Kojima, Tomohiko Taki, Noriko Nemoto, Kazumi Suzukawa, Naoyoshi Mori and Tsunehiko Komatsu and has published in prestigious journals such as Journal of Clinical Oncology, Colloids and Surfaces B Biointerfaces and Modern Pathology.

In The Last Decade

Naoko Takei

13 papers receiving 328 citations

Peers

Naoko Takei
Comparison fields: 5 of 89
  • Materials Chemistry 108
  • Molecular Biology 66
  • Electronic, Optical and Magnetic Materials 66
  • Biomaterials 63
  • Organic Chemistry 45
Replace Fangzhou Liu with:
Fangzhou Liu China
B.J.M. Leite Ferreira Portugal
Željka Stanojević Serbia
Katarzyna Wiglusz Poland
Xian He China
Sung Hwan Park South Korea
Yuping Han China
Bi Chen China
Fangzhou Liu China View profile →
Citations per field, relative to Naoko Takei
Naoko Takei · 1×
Citations per year, relative to Naoko Takei
Naoko Takei · 1×

Countries citing papers authored by Naoko Takei

Since Specialization
Citations

This map shows the geographic impact of Naoko Takei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Takei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Takei more than expected).

Fields of papers citing papers by Naoko Takei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Takei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Takei. The network helps show where Naoko Takei may publish in the future.

Co-authorship network of co-authors of Naoko Takei

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Takei. A scholar is included among the top collaborators of Naoko Takei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Takei. Naoko Takei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
# Work Indexed citations
1 34
2 1
3 1
4 3
5 2
6
[Current clinical practice in the treatment of febrile neutropenia (FN)].
1
7 3
8 36
9 3
10 4
11 18
12 27
13 194
14 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026